COVID-19 Updates
From the Journals
Evusheld PrEP may protect immunocompromised patients from severe COVID-19
Evusheld preexposure prophylaxis shows promise in protecting certain immunocompromised patients from severe COVID-19, Cleveland Clinic researchers...
Latest News
CDC: Masking no longer required in health care settings
The new guidance applies wherever health care is delivered, including nursing homes and home health.
Commentary
Why can’t U.K. immunocompromised patients get Evusheld?
This is about collecting more data and being as rational as possible. Can we accelerate that process? Perhaps.
Feature
FAQ: New COVID Omicron boosters
It’s also possible – but yet to be determined – that the new bivalent boosters will offer protection against newer but less common strains known...
From the Journals
Even mild COVID tied to vascular impairment
“It may encourage treating clinicians to be more aggressive with preventative neurovascular and cardiovascular health measures and/or screening in...
From the Journals
Risk factors linked to post–COVID vaccination death identified
Of note, the researchers said that “there was no association between the risk of COVID-19 death and ethnicity, except for those of Indian...
Feature
How do you live with COVID? One doctor’s personal experience
Early in 2020, Anne Peters, MD, caught COVID-19. The author of Medscape’s “Peters on Diabetes” column was sick in March 2020 before state-mandated...
From the Journals
Paxlovid reduces risk of COVID death by 79% in older adults
“Treatment with Paxlovid significantly reduces the risk of hospitalization and death from COVID-19.”
Conference Coverage
COVID-19 vaccine safe in patients with heart failure
There should be no concern about cardiovascular side effects from mRNA vaccines in patients with HF; moreover, vaccines provide a survival benefit...
News from the FDA/CDC
COVID to blame as U.S. life expectancy falls
The overall drop took national life expectancy from 78.8 years in 2019 to 77 years in 2020.
From the Journals
Metformin fails as early COVID-19 treatment but shows potential
Metformin may merit further investigation for adults who are overweight or obese.